Hims vs Calibrate for Weight Loss: GLP-1 Telehealth Programs Compared

Both Hims and Calibrate offer telehealth access to GLP-1 weight loss medications, but their approaches differ significantly in cost structure, medical oversight, and program intensity. Hims positions itself as an affordable, direct-pay option with monthly pricing, while Calibrate emphasizes comprehensive lifestyle coaching with higher upfront costs.

This comparison examines pricing, medication availability, physician oversight quality, and patient experience data to help you choose between these two popular telehealth weight loss programs. We analyzed current pricing from both companies' websites, reviewed clinical protocols, and evaluated user feedback to provide an evidence-based assessment.

The choice between Hims and Calibrate often comes down to budget, desired level of support, and insurance coverage preferences. Both platforms provide legitimate access to FDA-approved GLP-1 medications under physician supervision, but their service models target different patient needs and financial situations.

Quick Verdict: Hims vs Calibrate Comparison

Hims: What You Get

Hims operates a streamlined telehealth model focused on affordable access to GLP-1 medications without extensive lifestyle programming. The platform launched its weight loss program in 2022, leveraging its existing infrastructure for men's and women's health services.

The Hims weight loss program starts at $79 per month for semaglutide (compounded) and scales up to $199 monthly for brand-name tirzepatide (Mounjaro). These prices include the medication, physician consultation, and ongoing medical oversight through their messaging platform. The initial consultation involves completing a comprehensive health questionnaire and uploading recent lab work if available.

Hims offers two primary GLP-1 options: compounded semaglutide and brand-name tirzepatide. The semaglutide formulation is prepared by licensed compounding pharmacies and follows the same dosing protocol as Ozempic and Wegovy. Tirzepatide is dispensed as brand-name Mounjaro through their pharmacy partners. Both medications require dose escalation over 16-20 weeks to reach therapeutic levels.

The consultation process with Hims is entirely digital. After completing the intake questionnaire, a licensed physician reviews your medical history and determines medication eligibility. Approved patients receive their first shipment within 3-5 business days via temperature-controlled packaging. Follow-up care occurs through the Hims messaging platform, where patients can communicate with their prescribing physician about side effects, dose adjustments, or general questions.

Hims provides basic educational resources about GLP-1 medications, including injection technique videos and side effect management guides. However, the platform does not include structured lifestyle coaching, meal planning, or behavioral modification programs. The focus remains on medication access with minimal additional services.

Hims Pros:

• Lowest monthly pricing for GLP-1 access
• Fast shipping and delivery (3-5 days)
• Simple, streamlined process
• No long-term commitments required
• Established telehealth infrastructure

Hims Cons:

• Limited physician interaction (messaging only)
• No lifestyle coaching or meal planning
• Insurance not accepted
• Fewer medication options than competitors
• Minimal ongoing support beyond medication

Calibrate: What You Get

Calibrate positions itself as a comprehensive metabolic health program that combines GLP-1 medications with intensive lifestyle coaching and medical oversight. Founded in 2020 by medical professionals, Calibrate emphasizes the clinical evidence supporting combined pharmacotherapy and behavioral intervention for sustained weight loss.

Calibrate's pricing structure requires a $1,649 upfront payment for the first year, which includes all medical consultations, coaching sessions, and program materials. Medication costs are separate and range from $25-350 monthly depending on insurance coverage and specific GLP-1 prescribed. For patients paying out-of-pocket, the total first-year cost typically ranges between $3,000-5,500 including medications.

The platform offers three GLP-1 medications: semaglutide (Ozempic/Wegovy), tirzepatide (Mounjaro/Zepbound), and liraglutide (Saxenda). Calibrate physicians evaluate each patient's medical history, weight loss goals, and insurance coverage to determine the most appropriate medication. The program also incorporates metformin when clinically indicated for patients with insulin resistance or prediabetes.

Calibrate's medical oversight includes an initial comprehensive evaluation with a board-certified physician, followed by regular check-ins throughout the program. Patients have access to their prescribing doctor through the platform and can schedule video consultations as needed. The medical team monitors lab values, adjusts medications based on response and side effects, and coordinates care with patients' primary care physicians when necessary.

The lifestyle component of Calibrate includes weekly one-on-one coaching sessions with certified health coaches, personalized meal planning, sleep optimization guidance, and exercise programming. The coaching methodology is based on cognitive behavioral therapy principles and focuses on sustainable habit formation rather than restrictive dieting approaches.

Calibrate provides extensive educational resources through their mobile app, including recipe databases, progress tracking tools, and peer support communities. The program emphasizes four "pillars" of metabolic health: food, sleep, exercise, and emotional health. Patients work with their coach to develop personalized strategies in each area.

The platform accepts insurance from select plans, including some Blue Cross Blue Shield, Aetna, and employer-sponsored health plans. Insurance coverage typically applies to the medication costs but not the program fees. Calibrate's insurance team works with patients to verify benefits and maximize coverage where available.

Calibrate Pros:

• Comprehensive lifestyle coaching included
• Weekly video calls with certified coaches
• Three GLP-1 medication options
• Insurance accepted for medications
• Evidence-based behavioral intervention
• Extensive educational resources and app

Calibrate Cons:

Price Comparison: Hims vs Calibrate

The cost structures of Hims and Calibrate represent fundamentally different approaches to telehealth weight loss programs. Hims follows a straightforward monthly subscription model, while Calibrate requires significant upfront investment for comprehensive services.

Hims charges $79 monthly for compounded semaglutide and $199 monthly for brand-name tirzepatide. These prices include the medication, physician oversight, and basic support. Over 12 months, Hims patients pay $948 for semaglutide or $2,388 for tirzepatide. No additional fees apply, and patients can cancel anytime without penalty.

Calibrate's pricing includes a $1,649 program fee plus separate medication costs. Medication prices vary significantly based on insurance coverage. Patients with good insurance coverage may pay $25-50 monthly for medications, while those paying out-of-pocket typically spend $200-350 monthly. The total first-year cost for Calibrate ranges from $2,049 (with excellent insurance) to $5,849 (paying cash for everything).

For patients with insurance coverage for GLP-1 medications, Calibrate may offer better value despite higher program fees. The comprehensive coaching, medical oversight, and lifestyle programming justify the additional cost for patients seeking intensive support. However, for budget-conscious patients or those without insurance coverage, Hims provides significantly more affordable access to the same medications.

The break-even analysis favors Hims for patients focused primarily on medication access. Calibrate becomes cost-competitive for patients who would otherwise pay for separate nutrition coaching, fitness programming, or frequent medical consultations. The value proposition depends heavily on individual preferences for support intensity and available insurance benefits.

Medication Options: Hims vs Calibrate

Both platforms provide access to FDA-approved GLP-1 receptor agonists, but Calibrate offers a broader selection of medications and dosing options. The choice of medication often depends on insurance coverage, individual response patterns, and specific clinical considerations.

Hims offers compounded semaglutide and brand-name tirzepatide (Mounjaro). The compounded semaglutide follows the same active ingredient and dosing schedule as Ozempic and Wegovy but is prepared by licensed compounding pharmacies. This approach allows Hims to offer semaglutide at lower costs than brand-name versions. Tirzepatide is dispensed as brand-name Mounjaro through their pharmacy network.

Calibrate provides three GLP-1 options: semaglutide (brand-name Ozempic or Wegovy), tirzepatide (Mounjaro or Zepbound), and liraglutide (Saxenda). The platform prioritizes brand-name medications when insurance coverage allows, falling back to compounded versions when necessary for cost or availability reasons. Calibrate physicians also prescribe metformin as an adjunct therapy for patients with insulin resistance.

Clinical evidence supports the effectiveness of all three GLP-1 medications for weight loss. Tirzepatide demonstrates the highest average weight loss (15-22% of body weight) in clinical trials, followed by semaglutide (12-15%) and liraglutide (5-8%). However, individual responses vary significantly, and the "best" medication depends on factors like side effect tolerance, injection frequency preferences, and insurance coverage.

Calibrate's broader medication selection allows for more personalized treatment approaches. If a patient experiences intolerable side effects with one GLP-1, their physician can switch to an alternative without changing platforms. Hims patients may need to seek care elsewhere if their initial medication choice proves unsuitable.

Doctor Quality and Oversight

Both Hims and Calibrate employ licensed physicians to prescribe GLP-1 medications, but their models of medical oversight differ significantly in intensity and interaction frequency. The level of physician involvement often influences treatment outcomes and patient safety.

Hims physicians are licensed in multiple states and complete specialized training in telehealth weight management protocols. The initial consultation involves reviewing the patient's health questionnaire, medical history, and any available lab work. Ongoing oversight occurs through the messaging platform, where patients can ask questions about side effects, request dose adjustments, or discuss concerns. Response times typically range from 24-48 hours for non-urgent inquiries.

Calibrate employs board-certified physicians specializing in obesity medicine, endocrinology, or internal medicine. The initial evaluation is more comprehensive, often including a video consultation to discuss treatment goals, review medical history, and explain the integrated approach combining medication with lifestyle modification. Patients have ongoing access to their prescribing physician and can schedule additional video consultations as needed.

The frequency of medical check-ins differs between platforms. Hims physicians typically review patient progress monthly or when patients report concerns. Calibrate physicians conduct more frequent evaluations, especially during the initial dose escalation period, and maintain closer coordination with the coaching team to optimize both medical and behavioral interventions.

Both platforms require patients to monitor for potential side effects and report any concerning symptoms. However, Calibrate's more intensive oversight model may provide better early detection and management of adverse effects. The integrated approach also allows for more sophisticated treatment adjustments based on both medical response and lifestyle factors.

Patient Experience and Reviews

Patient satisfaction data reveals different strengths for each platform, reflecting their distinct service models and target audiences. Review patterns suggest that patient preferences align closely with expectations for support level and program intensity.

Hims receives positive reviews for simplicity, affordability, and fast medication delivery. Patients appreciate the straightforward process and lack of complicated program requirements. Common positive themes include easy prescription refills, responsive customer service, and effective medications. Negative reviews often cite limited physician interaction and lack of lifestyle support as drawbacks for patients seeking comprehensive weight loss assistance.

Calibrate earns high ratings for coaching quality, comprehensive support, and clinical outcomes. Patients frequently praise their health coaches, the educational resources, and the integrated approach to weight management. The platform's emphasis on sustainable lifestyle changes resonates with patients seeking long-term solutions rather than quick fixes. Negative reviews typically focus on high costs, time-intensive requirements, and occasional delays in medication shipping.

Third-party review platforms show Hims averaging 4.2/5 stars across major review sites, with particular strength in ease of use and value ratings. Calibrate maintains a 4.6/5 average, with highest scores for effectiveness and support quality. Both platforms demonstrate strong customer service responsiveness and medication quality consistency.

Patient outcome data suggests both platforms achieve clinically meaningful weight loss results. Hims reports average weight loss of 8-12% over 6 months for patients who complete the program. Calibrate publishes data showing 12-18% average weight loss over 12 months, though their more intensive program model may contribute to better long-term adherence and outcomes.

Which Is Right for You?

Choosing between Hims and Calibrate depends on your budget, desired level of support, insurance coverage, and personal preferences for medical care delivery. Both platforms provide legitimate access to effective GLP-1 medications under proper physician supervision.

Choose Hims if you: Want affordable medication access without extensive programming, prefer minimal time commitments, are comfortable with messaging-based physician communication, need fast medication delivery, or have limited budget for weight loss treatment. Hims works well for self-motivated patients who primarily need prescription access rather than comprehensive lifestyle support.

Choose Calibrate if you: Want comprehensive lifestyle coaching alongside medication, have insurance coverage for GLP-1s, prefer intensive medical oversight with video consultations, need structured support for sustainable habit changes, or are willing to invest significantly in a comprehensive program. Calibrate suits patients who benefit from accountability, education, and integrated medical-behavioral approaches.

For patients seeking a middle ground between these approaches, FormBlends offers physician-supervised GLP-1 programs with personalized dosing protocols and competitive pricing. Our clinical team provides more intensive oversight than typical telehealth platforms while maintaining cost-effectiveness for patients paying out-of-pocket.

Frequently Asked Questions

Do Hims and Calibrate prescribe the same medications?

Both platforms prescribe semaglutide and tirzepatide, but Calibrate offers additional options including liraglutide and metformin. Hims focuses on compounded semaglutide and brand-name tirzepatide, while Calibrate provides both brand-name and compounded versions depending on insurance coverage and clinical needs.

Which platform accepts insurance for GLP-1 medications?

Calibrate accepts insurance from select plans and works with patients to maximize coverage for medications. Hims operates on a direct-pay model and does not process insurance claims. Patients using Hims may be able to seek reimbursement independently, but the platform does not facilitate insurance billing.

How quickly can I start treatment with each platform?

Hims typically approves patients and ships medications within 3-5 business days of completing the consultation. Calibrate's process takes longer due to more comprehensive evaluation requirements, with medication delivery usually occurring 7-10 days after program enrollment and physician approval.

What happens if I experience side effects with either program?

Both platforms provide physician oversight for side effect management. Hims patients communicate with their doctor through messaging for dose adjustments or medication changes. Calibrate patients have access to both their prescribing physician and health coach for comprehensive side effect support, including lifestyle modifications to minimize GI symptoms.

Can I switch between these platforms if I'm unsatisfied?

Yes, both platforms allow patients to discontinue service, though Calibrate's upfront payment model means you may lose prepaid program fees. Switching between platforms requires a new consultation with the receiving platform's physicians, as medical records and prescriptions don't automatically transfer between competing telehealth companies.

Ready to Start Your Weight Loss Goals?

Both Hims and Calibrate offer legitimate pathways to GLP-1 weight loss medications with proper physician oversight. Your choice should align with your budget, support preferences, and treatment goals. Consider your insurance coverage, desired level of medical interaction, and commitment to lifestyle programming when making your decision.

For patients seeking personalized care with competitive pricing, FormBlends provides a free physician assessment to determine the most appropriate GLP-1 protocol for your individual needs. Our approach combines the affordability of direct-pay models with comprehensive medical oversight and customized treatment plans.

Regardless of which platform you choose, GLP-1 medications represent a significant advancement in weight management when used under proper medical supervision. The key to success lies in finding a program that matches your needs, preferences, and long-term sustainability requirements.

Sources

1. Hims & Hers Health, Inc. Weight Loss Program Pricing and Services. Accessed March 2026. https://www.hims.com/weight-loss
2. Calibrate Health. Program Overview and Pricing Structure. Accessed March 2026. https://www.calibrate.com/how-it-works
3. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002.
4. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216.
5. FDA. Medications Containing Semaglutide Marketed for Type 2 Diabetes or Weight Loss. Updated February 2026. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/medications-containing-semaglutide-marketed-type-2-diabetes-or-weight-loss